Drug · DIN 02366258
AVA-SUMATRIPTAN
No: no longer authorized
The company stopped selling it and its DIN was cancelled. A cancellation is most often a business decision; the record does not say why.
Status Cancelled Post Market since August 21, 2014; first marketed September 19, 2011.
- Drug Identification Number (DIN)
- 02366258
- Company (DIN owner)
- Avanstra IncCalgary, Alberta, Canada
- Schedule
- Prescription
- Dosage form
- Tablet
- Route
- Oral
- Therapeutic class (ATC)
- Sumatriptan N02CC01
- Class
- Human
- Record last updated
- June 18, 2026
Active ingredients
As listed in the Drug Product Database.
| Ingredient | Strength | Per |
|---|---|---|
| SUMATRIPTAN (SUMATRIPTAN SUCCINATE) | 50 MG |
Notices of Compliance
Health Canada approvals that name this DIN.
- September 6, 2011: NOC 12608Abbreviated New Drug Submission (ANDS) · New Manufacturer and Product Name
Other DINs named AVA-SUMATRIPTAN
- DIN 02366266 · Cancelled Post Market